25 May 2013
Keywords: skyepharma, work, altace, follow-up, uk, been, signed
Article | 26 May 2003
SkyePharma of the UK has been signed up by the USA's King Pharmaceuticals to develop a modified-release formulation of Altace
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 May 2003
19 May 2003
24 May 2013
© 2013 thepharmaletter.com